A liquid chromatographic-tandem mass spectrometric method for the determination of YM466, a novel Factor Xa inhibitor, in rat plasma.
A sensitive and selective method for the determination of YM466, a novel Factor Xa inhibitor, in rat plasma was developed and validated using liquid chromatography-mass spectrometry with electrospray ionization. Plasma samples were pretreated by solid-phase extraction and chromatographed on a C18 column (75 mm x 4.6 mm i.d.) with a mobile phase consisting of 0.1% formic acid-methanol (70:30 (v/v)), and detected using selected reaction monitoring in the positive-ion mode. The lower limit of quantification was 0.4 ng/ml, and good precision and accuracy were achieved. The validated method allowed analysis of samples for the determination of pharmacokinetic profiles of YM466 in rats.